Related Experiment Video
Updated: Jul 18, 2026

09:09
Removal and Replacement of Endogenous Ligands from Lipid-Bound Proteins and Allergens
Published on: February 24, 2021
Mantis shrimp allergy
R Eiró Alonso1, B Bartolomé Zavala, J M Soler Escoda
1ALLERCEN (Allergy Center) Barcelona, Spain.
Journal of Investigational Allergology & Clinical Immunology
|December 13, 2006
Summary
Mantis shrimp allergy can cause severe angioedema. This crustacean allergy study found cross-reactivity between mantis shrimp and other shellfish, indicating shared allergens like tropomyosin.
Area of Science:
- Allergy and Immunology
- Food Science
- Toxicology
Background:
- Crustacean consumption is common, but allergies can cause severe reactions.
- Mantis shrimp (Squilla empusa) is a less commonly reported allergen compared to other shellfish.
- Angioedema, particularly involving the larynx, poses a significant risk.
Observation:
- A 25-year-old female experienced recurrent angioedema (labial, lingual, laryngeal) after consuming mantis shrimp and shellfish pudding.
- Skin prick tests showed positive reactions to mantis shrimp and other crustaceans.
- Serum specific IgE levels were elevated against mantis shrimp, prawn, large prawn, and crab extracts.
Findings:
- Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) immunoblotting identified IgE-binding proteins in mantis shrimp at 46 kDa and 25 kDa.
- Enzyme allergo sorbent test (EAST)-inhibition and immunoblotting-inhibition assays revealed significant cross-reactivity between mantis shrimp allergens and those in prawns and crabs.
- Specific IgE to large prawn tropomyosin was below the detection limit, suggesting other allergens are involved.
Implications:
- This case highlights mantis shrimp as a potential allergen causing severe reactions.
- Cross-reactivity among crustaceans suggests a need for careful dietary advice for individuals with shellfish allergies.
- Further research into specific allergens, like tropomyosin and other proteins, is warranted for accurate diagnosis and management.
Related Concept Videos
Allergic Reactions
Overview
Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Cross-reactivity
Overview
Antiasthma Drugs: Muscarinic Receptor Antagonists
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...

